According to a feasibility study conducted by Neuros Medical, four of five patients reported their pain was reduced to zero after undergoing the company’s patented electrical nerve block technology.
Company officials plan to share more details about the feasibility study at the upcoming International Neuromodulation Society meeting in London this coming May.
Read the news release about nerve block technology (pdf).
Read other coverage about pain management:
– Mayo Clinic: Botox May Ease Spinal Headaches
– Study on Pain Relief Through Meditation May Fall Short
– Pain Specialist Reports 50% Patient Volume Drop, Partly Due to State HTA Committee
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.